Jürgen Michael Stein (J Stein, Jürgen Stein, Juergen Stein)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Venues

Alimentary pharmacology & therapeutics

Diagnostics (Basel, Switzerland)

Journal of clinical medicine

Scandinavian journal of gastroenterology

DGD Clinics Sachsenhausen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

DGD Clinics Sachsenhausen

Germany

Head of Department :: Gastroenterology and Clinical Nutrition

Interdisciplinary Crohn Colitis Centre Rhein-Main

Germany

Managing Director

Publications

Karima Farrag, Ayşegül Aksan, Valëza Ademaj-Kospiri, Eleni Leventi, Jürgen Michael Stein
Use of Biomarkers of Inflammation in the Differentiation of Iron Deficiency and Anaemia-Lessons from Inflammatory Bowel Disease. Diagnostics (Basel, Switzerland) 14 (14) (2024)
Karima Farrag, Ayşegül Aksan, Valëza Ademaj-Kospiri, Eleni Leventi, Jürgen Michael Stein
Use of Biomarkers of Inflammation in the Differentiation of Iron Deficiency and Anaemia-Lessons from Inflammatory Bowel Disease. Diagnostics (Basel, Switzerland) 14 (14) (2024)
Karima Farrag, Ayşegül Aksan, Valëza Ademaj-Kospiri, Eleni Leventi, Jürgen Michael Stein
Use of Biomarkers of Inflammation in the Differentiation of Iron Deficiency and Anaemia-Lessons from Inflammatory Bowel Disease. Diagnostics (Basel, Switzerland) 14 (14) (2024)
Hannah Gordon, Burisch J, Pierre Ellul, Konstantinos Karmiris, Konstantinos Katsanos, Mariangela Allocca, Giorgos Bamias, Manuel Barreiro-de Acosta, Tasanee Braithwaite, Thomas Greuter, Catherine Harwood, Pascal Juillerat, Triana Lobaton, Ulf Müller-Ladner, Nurulamin M Noor, Gianluca Pellino, Edoardo Vincenzo Savarino, Christoph Schramm, Alessandra Soriano, Jürgen Michael Stein, Mathieu Uzzan, Patrick Ferry van Rheenen, Stephan R Vavricka, Maurizio Vecchi, Stephane Zuily, Torsten Kucharzik
ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease. Journal of Crohn's & colitis (2023)
Johanna Erbach, Florian Bonn, Max Diesner, Anne Arnold, Jürgen Michael Stein, Oliver Schröder, Ayşegül Aksan
Relevance of Biotin Deficiency in Patients with Inflammatory Bowel Disease and Utility of Serum 3 Hydroxyisovaleryl Carnitine as a Practical Everyday Marker. Journal of clinical medicine 11 (4) (2022)
Heinfried H Radeke, Jürgen Michael Stein
Letter: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis-a unique therapeutic target in inflammatory bowel disease. Alimentary pharmacology & therapeutics 55 (10) (2022)
Sarah J Günthert, Aysegül Aksan, Oliver Schröder, Günther Meyer, Johannes Hausmann, Jürgen Michael Stein, Christine Stier
Glycemic control and BMI changes after endoscopic implantation of a duodenojejunal bypass liner compared with laparoscopic Roux-en-Y gastric bypass surgery: a propensity score matching analysis. Surgical endoscopy 36 (8) (2022)
Ayşegül Aksan, Axel U Dignass, Jürgen Michael Stein
Letter to the editor: in response to: Richard F Pollock & Patrick Biggar. Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia. Expert review of hematology (2021)
Ayşegül Aksan, Izzet Erdal, Siddika Songül Yalcin, Jürgen Michael Stein, Gülhan Samur
Osteopontin Levels in Human Milk Are Related to Maternal Nutrition and Infant Health and Growth. Nutrients 13 (8) (2021)
Eleni Leventi, Ayşegül Aksan, Carl Thomas Nebe, Jürgen Michael Stein, Karima Farrag
Zinc Protoporphyrin Is a Reliable Marker of Functional Iron Deficiency in Patients with Inflammatory Bowel Disease. Diagnostics (Basel, Switzerland) 11 (2) (2021)
Eleni Leventi, Sarah J Günthert, Christine Stier, Plamen Staikov, Jürgen Michael Stein, Karima Farrag
Is Early Reimplantation of the Duodenal-Jejunal Bypass Liner Viable? Obesity surgery 29 (5) (2020)
Wolfgang Alexander Seeger, Juliane Thieringer, Philip Esters, Benjamin Allmendinger, Jürgen Michael Stein, Hermann Schulze, Axel U Dignass
Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn's disease. United European gastroenterology journal 8 (7) (2020)
Giuseppe Rosano, Ingolf Schiefke, Udo-Michael Göhring, Vincent Fabien, Stefano Bonassi, Jürgen Michael Stein
A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose. Journal of clinical medicine 9 (11) (2020)
Ayşegül Aksan, Axel U Dignass, Jürgen Michael Stein
Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark. Advances in therapy 36 (8) (2019)
Ayşegül Aksan, Karima Farrag, Jürgen Michael Stein
An update on the evaluation and management of iron deficiency anemia in inflammatory bowel disease. Expert review of gastroenterology & hepatology 13 (2) (2018)
Jürgen Michael Stein, Andreas Walper, Wolfgang Klemm, Karima Farrag, Ayşegül Aksan, Axel U Dignass
Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice. Scandinavian journal of gastroenterology 53 (9) (2018)
Hermann Schulze, Philip Esters, Franz Hartmann, Jürgen Michael Stein, Christina Christ, Michael Zorn, Axel U Dignass
A prospective cohort study to assess the relevance of vedolizumab drug level monitoring in IBD patients. Scandinavian journal of gastroenterology 53 (6) (2018)
Axel U Dignass, Karima Farrag, Jürgen Michael Stein
Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions. International journal of chronic diseases 2018 (2018)
Ayşegül Aksan, H Işık, Heinfried H Radeke, Axel U Dignass, Jürgen Michael Stein
Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 45 (10) (2017)
Jürgen Michael Stein, Ayşegül Aksan, Karima Farrag, Axel U Dignass, Heinfried H Radeke
Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice. Expert opinion on pharmacotherapy 18 (16) (2017)
Ayşegül Aksan, H Işık, Heinfried H Radeke, Axel U Dignass, Jürgen Michael Stein
Editorial: which iron preparation for patients with IBD? Authors' reply. Alimentary pharmacology & therapeutics 46 (2) (2017)
Ayşegül Aksan, H Işık, Heinfried H Radeke, Axel U Dignass, Jürgen Michael Stein
Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies-authors' reply. Alimentary pharmacology & therapeutics 46 (7) (2017)
Ayşegül Aksan, H Işık, Heinfried H Radeke, Axel U Dignass, Jürgen Michael Stein
Letter: inconsistency in reporting of hypophosphataemia after intravenous iron-authors' reply. Alimentary pharmacology & therapeutics 46 (6) (2017)

Jürgen Michael Stein.css-eqlu8i{font-size:small;padding-left:4px;} (J Stein, Jürgen Stein, Juergen Stein)

Publication Activity (10 Years)

Top Topics

Top Venues

Jürgen Michael Stein (J Stein, Jürgen Stein, Juergen Stein)